|
US2021085630A1
|
|
Pharmaceutical composition and use thereof in preparing drug for treating tumor multi-drug resistance
|
|
WO2018103729A1
|
|
Use of chlorogenic acid in preparation of drugs or health-care products for stimulating appetite
|
|
CN105796542A
|
|
Application of chlorogenic acid in preparing drug for treating diseases with LAG-3 as target spot
|
|
WO2016127400A1
|
|
Use of chlorogenic acid in preparing drug for treating urticaria
|
|
WO2016127399A1
|
|
Use of chlorogenic acid in preparing drug for treating amyotrophic lateral sclerosis
|
|
WO2016127342A1
|
|
Use of chlorogenic acid in preparation of medicine for treating progeria
|
|
EP3251683A1
|
|
Eucommia leaf extract, and preparation method and use thereof
|
|
EP3207927A1
|
|
Use of chlorogenic acid in manufacturing medicaments for treating oligodendroglioma
|
|
KR20160128376A
|
|
Crystalline form of chlorogenic acid and preparation method therefor
|
|
US2016193176A1
|
|
Chlorogenic acid powder-injection and preparation method thereof
|
|
EP3037099A1
|
|
Pharmaceutical composition, preparation method therefor and use thereof
|
